Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
Camel vaccine against MERS show promise; E. coli keeps evolving in a constant environment; engineered cells treat psoriasis in mice; Congress considers NIH budget boost